Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Androgen receptor polymorphisms and risk of biochemical failure among prostatectomy patients.

The Prostate - 1 Sept 2004

Strom Sara S, Gu Yun, Zhang Hui, Troncoso Patricia, Babaian Richard J, Pettaway Curtis A, Shete Sanjay, Spitz Margaret R, Logothetis Christopher J

Abstract excerpt

BACKGROUND: Little is known about the role of inherited genotypes in prostate cancer (PC) progression. This prospective study evaluated the predictive value of androgen receptor (AR) polymorphisms (CAG and GGC repeats) among prostatectomy patients. METHODS: We studied 354 patients registered at M. D. Anderson Cancer Center from 1991 to 2001. Kaplan-Meier and Cox proportional hazard analyses were used. RESULTS:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Predictive Value of Tests

Share to Prostate-Specific Antigen

Share to Prostatectomy

Share to Prostatic Neoplasms

Share to Receptors, Androgen

Share to Trinucleotide Repeats

Source

Identifiers

PMID: 15264247
DOI: 10.1002/pros.20060

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Androgen receptor polymorphisms and risk of biochemical failure among prostatectomy patients.PMID 15264247Read ↗

A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.Semantic proximity Read ↗

Androgen Receptor CAG Repeats and Prostate CancerSemantic proximity Read ↗

The impact of CAG repeats in exon 1 of the androgen receptor on disease progression after prostatectomy.Semantic proximity Read ↗

Tandem CAG repeats of the androgen receptor gene and prostate cancer risk in black and white men.Semantic proximity Read ↗

The CAG-triplet in the androgen receptor gene and single-nucleotide polymorphisms in androgen pathway genes in patients with concomitant bladder and prostate cancer.Semantic proximity Read ↗

Androgen receptor CAG repeat polymorphism and risk of TMPRSS2:ERG-positive prostate cancer.Semantic proximity Read ↗

The place of androgen receptor gene mutation analysis in the molecular diagnosis of prostate cancer and genotype-phenotype relationship.Semantic proximity Read ↗

Molecular markers in sex hormone pathway genes associated with the efficacy of androgen-deprivation therapy for prostate cancer.Semantic proximity Read ↗

Role of an androgen receptor gene polymorphism in development of hormone refractory prostate cancer in Indian population.Semantic proximity Read ↗

Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.Semantic proximity Read ↗

Inherited variation in hormone-regulating genes and prostate cancer survival.Semantic proximity Read ↗

Genetic polymorphisms in oestrogen receptor-binding sites affect clinical outcomes in patients with prostate cancer receiving androgen-deprivation therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.